Anvisa analyzes eight medications with semaglutide; see what changes with the patent expiration
Brazil's health regulatory agency Anvisa is currently reviewing eight semaglutide-based drug applications following the recent patent expiration of the popular medications Ozempic and Wegovy.
Profarma purchases 4Bio from RD Saúde for R$ 600 million
Profarma has announced its acquisition of 4Bio Medicamentos from RD Saúde for R$ 600 million.